Skip to main content
. 2023 Mar 20;17:1521. doi: 10.3332/ecancer.2023.1521

Table 2: Showing treatment received by Seminoma and NSGCT.

Seminoma (n = 33)
Treatment received: Number (%)
NSGCT (n = 21)
Treatment received: Number(%)
3# BEP: 14 (42.2)
4# of EP: 5 (15.1)
Carboplatin (AUC-7): 8 (24.2)
Para-aortic RT: 1 (3.0)
2# BEP+ 2 EP: 1 (3.0)
4#VIP: 2 (6.0)
4# EP: 1 (4.76)
4# of BEP: 13 (61.9)
4#VIP: 3 (14.28)
4#TIP: 1(4.76)
2# BEP: 1(4.76)
3# BEP: 1 (4.76)
4 patients underwent RPLND (12.12%) 12 patients required RPLND
(57.14%)

AUC = Area under the curve; RPLND: Retroperitoneal lymph node dissection.